NASDAQ: CLRO

CLEARONE INC

CIK 0000840715 · SIC 3661 · Telephone & Telegraph Apparatus

Micro Assets $990K as of Sep 20, 2026

ClearOne, Inc. (the “Company,” “we,” “us” or “our”), a Delaware corporation, was previously engaged in the design, development, and marketing of professional audio conferencing, microphone, and video collaboration solutions. About this business →

Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.

Sign up free

Want to see a complete report first? Today's free report (SRBK 10-K) is open in full — no account needed.

S-1/A Filed Sep 4, 2026

Summary not yet generated.

8-K Filed Aug 26, 2026 · Period ending Aug 25, 2026

Summary not yet generated.

Partner

Trade CLRO commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

10-Q Filed Aug 14, 2026 · Period ending Jun 30, 2026

Summary not yet generated.

8-K Filed Aug 11, 2026 · Period ending Aug 7, 2026

Summary not yet generated.

S-1 Filed Aug 10, 2026 Red flag

ClearOne (CLRO) offers 2.9M-4.3M units at $3.50/unit (stock + warrant) to raise $9.1M-$13.8M net proceeds, conditioned on merger with pre-revenue neurostimulation developer Cortigent

7 material changes detected. Sign up free to read the summary.

8-K Filed Aug 5, 2026 · Period ending Jul 31, 2026

Summary not yet generated.

8-K Filed Jul 6, 2026 · Period ending Jul 6, 2026

Summary not yet generated.

8-K Filed Jul 1, 2026 · Period ending Jul 1, 2026

Summary not yet generated.

10-Q Filed May 15, 2026 · Period ending Mar 31, 2026

Summary not yet generated.

10-K Filed Mar 31, 2026 · Period ending Dec 31, 2025

Summary not yet generated.

10-Q Filed Nov 14, 2025 · Period ending Sep 30, 2025

Summary not yet generated.

10-K/A Filed Apr 25, 2025 · Period ending Dec 31, 2024

Summary not yet generated.

10-K Filed Mar 28, 2025 · Period ending Dec 31, 2024

Summary not yet generated.

S-1 Filed Oct 15, 2020

Summary not yet generated.

424B5 Filed Sep 15, 2020

Summary not yet generated.

424B3 Filed Nov 14, 2018

Summary not yet generated.

424B1 Filed Nov 5, 2018

Summary not yet generated.

S-1/A Filed Nov 1, 2018

Summary not yet generated.

S-1 Filed Sep 26, 2018

Summary not yet generated.

10-Q/A Filed Jan 13, 2016 · Period ending Jun 30, 2015

Summary not yet generated.

Latest financial statements

From 10-Q filed Aug 14, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.

As filed

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

(Dollars in thousands, except per share amounts)

Description Three months ended June 30, 2026 Three months ended June 30, 2025 Six months ended June 30, 2026 Six months ended June 30, 2025
Revenue — — — —
Cost of goods sold 70 100 140 127
Gross profit (loss) (70) (100) (140) (127)
Operating expenses:
Sales and marketing — — — —
Research and product development — — — —
General and administrative 849 1,092 1,629 1,891
Total operating expenses 849 1,092 1,629 1,891
Operating loss (919) (1,192) (1,769) (2,018)
Interest (expense) — (8) — (8)
Other income, net — 3 — 15
Loss from continuing operations before income taxes (919) (1,197) (1,769) (2,011)
Provision for income taxes — 8 — 8
Loss from continuing operations (919) (1,205) (1,769) (2,019)
Income (loss) from discontinued operations, net of tax 5 (3,367) 368 (5,387)
Net loss (914) (4,572) (1,401) (7,406)
Basic weighted average shares outstanding 2,675,412 1,733,307 2,530,384 1,691,836
Diluted weighted average shares outstanding 2,675,412 1,733,307 2,530,384 1,691,836
Basic income (loss) per share
From continuing operations (0.34) (0.70) (0.70) (1.19)
From discontinued operations 0.00 (1.94) 0.15 (3.19)
Total (0.34) (2.64) (0.55) (4.38)
Diluted income (loss) per share
From continuing operations (0.34) (0.70) (0.70) (1.19)
From discontinued operations 0.00 (1.94) 0.15 (3.19)
Total (0.34) (2.64) (0.55) (4.38)
Comprehensive loss:
Net loss (914) (4,572) (1,401) (7,406)
Change in foreign currency translation adjustment 1 (10) — (23)
Comprehensive loss (913) (4,582) (1,401) (7,429)

Condensed Consolidated Balance Sheets (Unaudited)

(Dollars in thousands, except par value)

Description June 30, 2026 December 31, 2025
ASSETS
Current assets:
Cash and cash equivalents 75 220
Restricted cash 447 519
Inventories, net 304 353
Prepaid assets 10 —
Current assets related to discontinued operations 140 604
Total current assets 976 1,696
Operating lease right of use assets, net — 494
Long term assets related to discontinued operations 14 109
Total assets 990 2,299
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Accounts payable 244 30
Accrued liabilities 185 649
Short term Note Payable 500 —
Current operating lease liability — 223
Current liabilities related to discontinued operations — 585
Total current liabilities 929 1,487
Long term operating lease liability — 290
Long-term liabilities related to discontinued operations 442 1,236
Total liabilities 1,371 3,013
Shareholders' equity:
Class B convertible preferred stock, par value $0.001, 5,100 shares authorized, and — shares issued and outstanding, respectively — —
Common stock, par value $0.001, 150,000,000 shares authorized, 2,675,412 and 2,237,912 shares issued and outstanding, respectively 3 2
Additional paid-in capital 37,500 35,767
Accumulated other comprehensive loss (340) (340)
Accumulated deficit (37,544) (36,143)
Total shareholders' equity (381) (714)
Total liabilities and shareholders' equity 990 2,299

Condensed Consolidated Statements of Cash Flows (Unaudited)

(Dollars in thousands, except per share amounts)

Description Six months ended June 30, 2026 Six months ended June 30, 2025
Cash flows from operating activities:
Net loss (1,401) (7,406)
Adjustments to reconcile net loss to net cash used in operating activities:
Share-based compensation expense — 44
Changes in operating assets and liabilities:
Inventories 49 —
Prepaid expenses and other assets (10) —
Accounts payable 225 92
Accrued liabilities (448) 219
Operating lease liabilities — (1)
Net cash used in operating activities, continuing operations (1,585) (7,052)
Cash provided by (used in) operating activities, discontinued operations (860) 4,484
Cash flows from investing activities:
Net cash provided by investing activities, continuing operations — —
Cash used in investing activities, discontinued operations — (21)
Cash flows from financing activities:
Proceeds from sale of stock 1,750 1,000
Proceeds from issuance of convertible note — 3,000
Proceeds from issuance of short-term note 500
Purchases of outstanding warrants (22) —
Net cash provided by financing activities, continuing operations 2,228 4,000
Cash provided by financing activities, discontinued operations — —
Effect of exchange rate changes on cash and cash equivalents — (18)
Net increase (decrease) in cash and cash equivalents (217) 1,393
Cash, cash equivalents and restricted cash at the beginning of the period 739 1,417
Cash, cash equivalents and restricted cash at the end of the period 522 2,810

Amounts as printed on the EDGAR/iXBRL face — (Dollars in thousands, except per share amounts); (Dollars in thousands, except par value). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗

About CLEARONE INC

Source: Item 1 (Business) from the 10-K filed March 31, 2026. Description as filed by the company with the SEC.

ITEM 1. BUSINESS

GENERAL

ClearOne, Inc. (the “Company,” “we,” “us” or “our”), a
Delaware corporation, was previously engaged in the design, development, and
marketing of professional audio conferencing, microphone, and video
collaboration solutions.

All share and per-share amounts presented in this report (current and historical) have been adjusted to reflect the 15-for-1 reverse stock split effected in June 2025.

October 2025 Asset Sale

On October 24, 2025, the Company completed the sale of
certain intellectual property, product inventory, and non-exclusive rights to
customer data to Biamp Systems, LLC (“Biamp”) for gross cash consideration of
$3.0 million (the “Asset Sale”) pursuant to an Asset Purchase Agreement dated
the same date. Biamp did not assume any warranty or technical support
obligations. The Company retained its books and records, all equity interests
in subsidiaries, certain minor assets (including a limited amount of inventory
held solely to service warranties), and all public-company assets and
obligations. See Note 2 to the Consolidated Financial Statements and the Company’s Current Report on
Form 8-K filed October 30, 2025 for additional information regarding the Asset
Sale.

Post-Asset-Sale Operations

Following the Asset Sale, the Company no longer manufactures or sells products and maintains a limited inventory and provides customer support services to satisfy warranty claims. Its continuing activities consist solely of (i) fulfilling warranty and technical support obligations on legacy products in accordance with published policies, (ii) managing and liquidating remaining assets of the Company's legacy operating business, (iii) evaluating potential strategic transactions; (iv) collecting accounts receivable and recovering prepaid assets, (v) satisfying outstanding liabilities, and (vi) maintaining public-company compliance. These activities are transitional in nature and are not expected to generate material revenue.

Read full description ↓

Strategy and Strategic Alternatives

The Company is actively evaluating strategic alternatives intended to enhance stockholder value. These alternatives may include without limitation one or more special transactions, an investment in, or an acquisition of a private operating company, additional asset sales, or other actions that maximize value for stockholders. The closing of the Asset Sale on October 24, 2025 triggered the mandatory redemption of all outstanding shares of the Company’s Class A Redeemable Preferred Stock. The Company currently estimates the final redemption amount will be approximately $50 after permitted expenses and net asset recoveries. There can be no assurance that any strategic transaction will be completed on favorable terms or at all.

Significant Ownership Changes

On November 24, 2025, Edward D. Bagley sold 700,000
shares of common stock to First Finance Ltd. As of December 31, 2025, First
Finance Ltd. beneficially owned approximately 53.8% of our outstanding common
stock. Any material changes in ownership after December 31, 2025 are disclosed
as subsequent events where required.

Company Information

Our website address is www.clearone.com.
We make our annual, quarterly, and current reports available free of charge on
the “Investor Relations” section of our website as soon as reasonably
practicable after filing with the SEC. The SEC maintains a website at
www.sec.gov that contains reports, proxy statements, and other information
regarding issuers that file electronically.

For a discussion of certain risks applicable to
our business, results of operations, financial position, and liquidity, see the
risk factors described in “Item 1A, Risk Factors” below.